Mga Batayang Estadistika
| LEI | 98450048403E01089069 |
| CIK | 1790169 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Flora Growth Corp.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2025 ( August 25, 2025 ) FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission |
|
| August 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2025 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of inc |
|
| August 4, 2025 |
For questions or more information to complete this form, please refer to the instruction page. Articles of Amendment Business Corporations Act Instructions For questions or more information to complete this form, please refer to the instruction page. |
|
| August 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40397 Flora Growt |
|
| June 30, 2025 |
Form of Vested Stock Appreciation Rights Agreement, dated June 30, 2025 Stock Appreciation Rights Agreement This Stock Appreciation Rights Agreement ("SAR Agreement") evidences the grant to (the "Participant") by Flora Growth Corp. |
|
| June 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2025 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of inco |
|
| June 30, 2025 |
Form of Unvested Stock Appreciation Rights Agreement, dated June 30, 2025 Stock Appreciation Rights Agreement This Stock Appreciation Rights Agreement ("SAR Agreement") evidences the grant to (the "Participant") by Flora Growth Corp. |
|
| June 30, 2025 |
2022 Incentive Compensation Plan FLORA GROWTH CORP. 2022 INCENTIVE COMPENSATION PLAN FLORA GROWTH CORP. 2022 INCENTIVE COMPENSATION PLAN 1. Purpose 1 2. Definitions 1 3. Administration. 6 4. Shares Subject to Plan. 7 5. Eligibility 8 6. Specific Terms of Awards. 8 7. Certain Provisions Applicable to Awards. 14 8. Change in Control. 17 9. General Provisions. 19 FLORA GROWTH CORP. 2022 INCENTIVE COMPENSATION PLAN 1. Purpose. The pu |
|
| May 20, 2025 |
CORRESP 1 filename1.htm May 20, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Request for Acceleration - Flora Growth Corp. Registration Statement on Form S-3 Filed May 14, 2025 (File No. 333-287261) Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Flo |
|
| May 14, 2025 |
As filed with the Securities and Exchange Commission on May 14, 2025 As filed with the Securities and Exchange Commission on May 14, 2025 Registration No. |
|
| May 14, 2025 |
Calculation of Filing Fee Tables FORM S-3 (Form Type) FLORA GROWTH CORP. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registe |
|
| May 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40397 Flora Grow |
|
| May 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| May 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2025 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of incorp |
|
| May 2, 2025 |
Form of Securities Purchase Agreement dated May 2, 2025 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of May 2, 2025, between Flora Growth Corp. |
|
| April 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☑ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 25, 2025 |
SUBMISSION VIA EDGAR March 25, 2025 Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission 100 F Street, N. |
|
| March 25, 2025 |
March 26, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| March 25, 2025 |
As filed with the Securities and Exchange Commission on March 25, 2025 As filed with the Securities and Exchange Commission on March 25, 2025 Registration No. |
|
| March 24, 2025 |
Flora Growth Corp. Insider Trading Policy EXHIBIT 19.1 FLORA GROWTH CORP. INSIDER TRADING POLICY A. SCOPE These Trading Procedures regulate securities trades by all directors and executive officers of the Company and certain designated employees (which initially shall be all employees), as well as certain designated consultants and contractors of the Company and its subsidiaries who in the ordinary course of the performance of their dutie |
|
| March 24, 2025 |
Flora Growth Corp Incentive Compensation Recovery Policy EXHIBIT 97 FLORA GROWTH CORP. INCENTIVE COMPENSATION RECOVERY POLICY 1. Introduction. The Board of Directors of Flora Growth Corp. (the "Company") believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company's compensation philosophy. The Board has therefore adopted this p |
|
| March 24, 2025 |
EXHIBIT 21.1 Subsidiaries Country of Incorporation Ownership % Functional Currency Vessel Brand Inc. United States 100% United States Dollar (USD) Vessel Brand Canada Inc. Canada 100% United States Dollar (USD) Just Brands LLC United States 100% United States Dollar (USD) Just Brands FL LLC United States 100% United States Dollar (USD) Just Brands International LTD United Kingdom 100% British Poun |
|
| March 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024. |
|
| February 28, 2025 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2025 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of |
|
| February 24, 2025 |
EXHIBIT 107 CALCULATION OF FILING FEE TABLES Form S-3 (Form Type) FLORA GROWTH CORP. |
|
| February 24, 2025 |
As filed with the Securities and Exchange Commission on February 24, 2025 As filed with the Securities and Exchange Commission on February 24, 2025 Registration No. |
|
| February 5, 2025 |
Share Purchase Agreement dated January 30, 2025 SHARE PURCHASE AGREEMENT This Share Purchase Agreement (this "Agreement"), dated as of January 30, 2025, is entered into between the Sellers set forth on Appendix A to this Agreement (together, the "Sellers"), and Flora Growth Corp, an Ontario corporation ("Buyer"). |
|
| February 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2025 ( January 30, 2025 ) FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commissi |
|
| February 5, 2025 |
Form of Promissory Note of Flora Growth Corp., dated January 30, 2025 PROMISSORY NOTE [Date] $[Amount] [Location] FOR VALUE RECEIVED, Flora Growth Corp ("Maker"), hereby promises to pay to the order of [Seller] ("Holder"), at any location designated by Holder, the sum of [Amount Written Out] ($[Amount in Numbers]) together with simple interest on the principal amount outstanding, on the following terms: 1. |
|
| January 21, 2025 |
JOINT ACQUISITION STATEMENT PURSUANT TO RULE 13d-1(k) EXHIBIT 99.1 JOINT ACQUISITION STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The unders |
|
| December 17, 2024 |
FLGC / Flora Growth Corp. / Starke Clifford - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 5 TO SCHEDULE 13D Under the Securities Exchange Act of 1934 Flora Growth Corp. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 339764102 (CUSIP Number) Clifford Starke Pia Porras 75 San Francisco Panama City, Panama With a copy to: Richard Raymer Dorsey & Whitney LLP 66 Wellington Stre |
|
| December 17, 2024 |
FLGC / Flora Growth Corp. / Vaiman Dany - SC 13D/A Activist Investment SC 13D/A 1 ef20040312sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO SCHEDULE 13D Under the Securities Exchange Act of 1934 Flora Growth Corp. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 339764102 (CUSIP Number) Dany Vaiman Flora Growth Corp. 3230 W. Commercial Blvd., Suite 180 Fort Lauderdale, FL 33309 |
|
| December 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): (December 15, 2024) FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer o |
|
| December 17, 2024 |
Form of Stock Appreciation Rights Agreement dated December 15, 2024 Stock Appreciation Rights Agreement This Stock Appreciation Rights Agreement ("SAR Agreement") evidences the grant to (the "Participant") by Flora Growth Corp. |
|
| December 17, 2024 |
Form of Restricted Stock Award Agreement dated December 15, 2024 FLORA GROWTH CORP. 2022 INCENTIVE COMPENSATION PLAN NOTICE OF GRANT OF SHARES OF RESTRICTED STOCK Notice is hereby given of the following grant by Flora Growth Corp., (the "Company"), of the number of Shares of Restricted Stock specified below pursuant to the Flora Growth Corp. 2022 Incentive Compensation Plan (the "Plan"), and subject to the terms and conditions set forth in this Notice, the atta |
|
| December 16, 2024 |
SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this "Agreement") is dated as of December 13, 2024, between Flora Growth Corp. |
|
| December 16, 2024 |
FLORA GROWTH CORP. 2,850,000 Common Shares Filed Pursuant to Rule 424(b)(5) Registration No. 333-274204 Prospectus Supplement to Prospectus dated September 6, 2023 FLORA GROWTH CORP. 2,850,000 Common Shares We are offering 2,850,000 of our common shares, no par value per share (the "common shares"), directly to certain investors, referred to as "the investors." Our common shares are listed on the Nasdaq Capital Market under the symbol "FLG |
|
| December 16, 2024 |
Placement Agent Agreement, dated as of December 13, 2024, by and between the Company and Aegis December 13, 2024 PERSONAL AND CONFIDENTIAL Mr. Clifford Starke, Chief Executive Officer Flora Growth Corp. 3406 SW 26th Terrace, Suite C-1 Fort Lauderdale, Florida 33312 Re: FLGC | Registered Direct Shelf Takedown | Placement Agent Agreement Dear Mr. Starke: The purpose of this placement agent agreement is to outline our agreement pursuant to which Aegis Capital Corp. ("Aegis") will act as the pl |
|
| December 16, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2024 (December 13, 2024) FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commissi |
|
| December 12, 2024 |
Termination of a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of |
|
| December 12, 2024 |
EX-1.1 2 exhibit1-1.htm EXHIBIT 1.1 December 10, 2024 PERSONAL AND CONFIDENTIAL Mr. Clifford Starke, Chief Executive Officer Flora Growth Corp. 3406 SW 26th Terrace, Suite C-1 Fort Lauderdale, Florida 33132 Re: FLGC | Placement Agent Agreement Dear Mr. Starke: The purpose of this placement agent agreement is to outline our agreement pursuant to which Aegis Capital Corp. ("Aegis") will act as the p |
|
| December 12, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of |
|
| December 12, 2024 |
424B3 1 form424b3.htm FORM 424B3 Filed pursuant to Rule 424(b)(3) Registration No. 333-274204 SUPPLEMENT NO 1. DATED December 12, 2024 TO PROSPECTUS SUPPLEMENT DATED April 26, 2024 (To Prospectus Dated September 6, 2023) Flora Growth Corp. This Supplement No. 1 to Prospectus Supplement (this "Supplement") supplements and amends the Prospectus Supplement dated April 26, 2024 (the "Prospectus Supple |
|
| December 12, 2024 |
Flora Growth Corp. 44,910,179 Common Shares Filed Pursuant to Rule 253(g)(3) File No. 024-12465 OFFERING CIRCULAR Flora Growth Corp. 44,910,179 Common Shares By this offering circular (the “Offering Circular”), Flora Growth Corp., an Ontario, Canada corporation, is offering on a “best-efforts” basis a maximum of 44,910,179 its common shares, no par value, at a fixed price of $1.67 per share, pursuant to Tier 2 of Regulation A (“Regulation A |
|
| December 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of i |
|
| December 9, 2024 |
December 9, 2024 VIA EDGAR Nicholas Panos Brian Soares Office of Mergers and Acquisitions United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D. |
|
| November 22, 2024 |
POST QUALIFICATION AMENDMENT TO OFFERING CIRCULAR EXPLANATORY NOTE POST QUALIFICATION AMENDMENT TO OFFERING CIRCULAR EXPLANATORY NOTE This post-qualification amendment no. |
|
| November 22, 2024 |
CONSENT OF INDEPENDENT AUDITOR CONSENT OF INDEPENDENT AUDITOR We consent to theuse in the Offering Circular constituting a part of this Offering Statement on Post-Qualification Amendment No. |
|
| November 14, 2024 |
FLGC / Flora Growth Corp. / Global X Management CO LLC - SC 13G/A Passive Investment SC 13G/A 1 ef20038664sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION STATEMENT TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b) (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (b) (Amendment No. 2)* Flora Growth Corp. (Name of Issuer) Common Shares (Title of Class of Securities) 339764201 (CUSIP Numb |
|
| November 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40397 Flora |
|
| November 1, 2024 |
SUPPLY AGREEMENT This Supply Agreement is made as of the 31st day of October, 2024 (the "Effective Date") between NORTHERN GREEN CANADA INC. |
|
| November 1, 2024 | ||
| November 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of i |
|
| October 15, 2024 |
Escrow Agreement This ESCROW AGREEMENT (this "Agreement") made as of [*], 2024, by and among Flora Growth Corp. |
|
| October 15, 2024 |
POST QUALIFICATION AMENDMENT TO OFFERING CIRCULAR EXPLANATORY NOTE POST QUALIFICATION AMENDMENT TO OFFERING CIRCULAR EXPLANATORY NOTE This post-qualification amendment no. |
|
| October 15, 2024 |
CONSENT OF INDEPENDENT AUDITOR CONSENT OF INDEPENDENT AUDITOR We consent to the use in the Offering Circular constituting a part of this Offering Statement on Post-Qualification Amendment No. |
|
| September 12, 2024 |
FLGC / Flora Growth Corp. / Vaiman Dany - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Flora Growth Corp. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 339764102 (CUSIP Number) Dany Vaiman Flora Growth Corp. 3230 W. Commercial Blvd., Suite 180 Fort Lauderdale, FL 33309 With a copy to: Richard Raymer Dorsey & Whitney LLP 66 Welli |
|
| September 11, 2024 |
FLGC / Flora Growth Corp. / Starke Clifford - AMENDMENT 4 TO SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 4 TO SCHEDULE 13D Under the Securities Exchange Act of 1934 Flora Growth Corp. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 339764102 (CUSIP Number) Clifford Starke Pia Porras 75 San Francisco Panama City, Panama With a copy to: Richard Raymer Dorsey & Whitney LLP 66 Wellington Stre |
|
| September 10, 2024 |
EXHIBIT 107 Calculation of Filing Fee Tables FORM S-8 (Form Type) FLORA GROWTH CORP. |
|
| September 10, 2024 |
Flora Growth Corp. 2022 Incentive Compensation Plan, as amended on June 6, 2023 and August 14, 2024 FLORA GROWTH CORP. 2022 INCENTIVE COMPENSATION PLAN, AS AMENDED ON JUNE 6, 2023 AND AUGUST 14, 2024 FLORA GROWTH CORP. 2022 INCENTIVE COMPENSATION PLAN, AS AMENDED ON JUNE 6, 2023 AND AUGUST 14, 2024 1. Purpose 1 2. Definitions 1 3. Administration. 5 4. Shares Subject to Plan. 6 5. Eligibility 7 6. Specific Terms of Awards. 7 7. Certain Provisions Applicable to Awards. 11 8. Change in Control. 14 |
|
| September 10, 2024 |
As filed with the Securities and Exchange Commission on September 10, 2024 As filed with the Securities and Exchange Commission on September 10, 2024 Registration No. |
|
| September 5, 2024 |
Form of Stock Appreciation Rights Agreement Stock Appreciation Rights Agreement This Stock Appreciation Rights Agreement ("SAR Agreement") evidences the grant to (the "Participant") by Flora Growth Corp. |
|
| September 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of in |
|
| August 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 26, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of in |
|
| August 14, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of in |
|
| August 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-52776 Flora Growt |
|
| August 7, 2024 |
August 6, 2024 Flora Growth Corp. 3406 SW 26th Terrace, Suite C-1 Fort Lauderdale, Florida 33132 Dear Sirs/Mesdames: RE: FLORA GROWTH CORP. We have acted as local counsel in Ontario to Flora Growth Corp., a corporation incorporated under the Business Corporations Act (Ontario) (the "Corporation") in connection with the preparation and filing of an offering statement on Form 1-A (the "Offering Stat |
|
| August 7, 2024 |
July 29, 2024 PERSONAL AND CONFIDENTIAL Mr. Clifford Starke, Chief Executive Officer Flora Growth Corp. 3230 W. Commercial Boulevard, Suite 180 Fort Lauderdale, Florida, United States 33309 Re: Flora Growth Corp. | Regulation A | Engagement Letter Dear Mr. Starke: The purpose of this engagement letter is to outline our agreement pursuant to which Aegis Capital Corp. ("Aegis") will act as the exclu |
|
| August 7, 2024 |
CONSENT OF INDEPENDENT AUDITOR CONSENT OF INDEPENDENT AUDITOR We consent to the use in the Offering Circular constituting a part of this Offering Statement on Form 1-A, as it may be amended, of our audit report dated March 28, 2024 with respect to the consolidated statements of financial position of Flora Growth Corp. |
|
| August 7, 2024 |
PRELIMINARY OFFERING CIRCULAR DATED AUGUST 6, 2024 PRELIMINARY OFFERING CIRCULAR DATED AUGUST 6, 2024 AN OFFERING STATEMENT PURSUANT TO REGULATION A RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. |
|
| August 7, 2024 |
[*] PERSONAL AND CONFIDENTIAL Mr. Clifford Starke, Chief Executive Officer Flora Growth Corp. 3406 SW 26th Terrace, Suite C-1 Fort Lauderdale, Florida 33132 Re: FLGC | Placement Agent Agreement Dear Mr. Hayes: The purpose of this placement agent agreement is to outline our agreement pursuant to which Aegis Capital Corp. ("Aegis") will act as the placement agent on a "best efforts" basis in connect |
|
| August 7, 2024 |
NOTICE TO INVESTORS THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK, SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. |
|
| August 6, 2024 |
August 6, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F. |
|
| July 16, 2024 |
CONSENT OF INDEPENDENT AUDITOR CONSENT OF INDEPENDENT AUDITOR We consent to the use in the Offering Circular constituting a part of this Offering Statement on Form 1-A, as it may be amended, of our audit report dated March 28, 2024 with respect to the consolidated statements of financial position of Flora Growth Corp. |
|
| July 16, 2024 |
June 19, 2024 PERSONAL AND CONFIDENTIAL Mr. Clifford Starke, Chief Executive Officer Flora Growth Corp. 3230 W. Commercial Boulevard, Suite 180 Fort Lauderdale, Florida, United States 33309 Re: Flora Growth Corp. | Regulation A | Engagement Letter Dear Mr. Starke: The purpose of this engagement letter is to outline our agreement pursuant to which Aegis Capital Corp. ("Aegis") will act as the exclu |
|
| July 16, 2024 |
PRELIMINARY OFFERING CIRCULAR DATED JULY 16, 2024 PRELIMINARY OFFERING CIRCULAR DATED JULY 16, 2024 AN OFFERING STATEMENT PURSUANT TO REGULATION A RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. |
|
| June 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| June 27, 2024 |
FLGC / Flora Growth Corp. / RDS PRIVATE CAPITAL II, LP - SCHEDULE 13G Passive Investment SC 13G 1 sc13g.htm SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 Flora Growth Corp. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 339764201 (CUSIP Number) April 22, 2024 (Date of Event Which Requires Filing of This Statement) Check the |
|
| June 21, 2024 |
June 21, 2024 VIA EDGAR Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission 100 F Street, N. |
|
| June 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☑ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e |
|
| June 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of incor |
|
| June 5, 2024 |
Execution Version SHARE PURCHASE AGREEMENT This Share Purchase Agreement (this "Agreement"), dated as of June 4, 2024 is entered into between LIFEIST WELLNESS INC. |
|
| June 4, 2024 |
TruHC Pharma GmbH Unaudited Condensed Financial Statements For the Three Months Ended March 31, 2024 and 2023 1 TruHC Pharma GmbH Condensed Interim Statements of Financial Position As at March 31, 2024 and December 31, 2023 (in Euros) March 31, 2024 December 31, 2023 As at: ASSETS Current Cash € 13,899 € 13,588 Amounts receivable 21,182 18,894 Prepaid expenses and other current assets 20,347 20,34 |
|
| June 4, 2024 |
Adjustments As at March 31, 2024 Assets Flora Growth Corp. TruHC Pharma GmbH Note Acquisition of TruHC Pharma GmbH Consolidated Cash and cash equivalents 4,156 15 2b (138 ) 3,933 2c (100 ) Restricted cash 35 - - 35 Trade and amounts receivables 7,281 23 - 7,304 Prepaid expenses and deposits 1,049 22 - 1,071 Inventory 9,246 - - 9,246 Total current assets 21,767 60 (238 ) 21,589 Plant, plant and equ |
|
| June 4, 2024 |
TruHC Pharma GmbH Financial Statements For the periods ended December 31, 2023 and 2022 TruHC Pharma GmbH Financial Statements For the periods ended December 31, 2023 and 2022 1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders and Directors of TruHC Pharma GmbH Opinion on the Financial Statements We have audited the accompanying statement of financial position of TruHC Pharma GmbH (the “Company”), as of December 31, 2023, and the related statements of loss and comprehensive loss, shareholders’ equity (deficiency), and cash flows for the year ended December 31, 2023 and the related notes (collectively referred to as the “financial statements”). |
|
| June 4, 2024 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission |
|
| May 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☑ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| May 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-52776 Flora Grow |
|
| May 7, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of incorp |
|
| May 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of incorp |
|
| April 30, 2024 |
April 30, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| April 29, 2024 |
Sales Agreement by and among Flora Growth Corp. and Aegis Capital Corp., dated April 26, 2024 FLORA GROWTH CORP. Common Shares (no par value) At-The-Market Issuance Sales Agreement April 26, 2024 Aegis Capital Corp. 1345 Avenue of the Americas, 27th Floor New York, New York 10015 Ladies and Gentlemen: Flora Growth Corp., an Ontario corporation (the "Company"), confirms its agreement (this "Agreement") with Aegis Capital Corp. ("Aegis"), as follows: 1. Issuance and Sale of Shares. The Compa |
|
| April 29, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of inc |
|
| April 26, 2024 |
(To Prospectus dated September 6, 2023) Up to $3,794,000 Common Shares FLORA GROWTH CORP. Filed Pursuant to Rule 424(b)(5) Registration No. 333-274204 (To Prospectus dated September 6, 2023) Up to $3,794,000 Common Shares FLORA GROWTH CORP. Flora Growth Corp. (the "Company" or "Flora") is offering to sell common shares, no par value, of the Company (the "common shares"), having an aggregate offering price of up to $3,794,000 pursuant to this prospectus supplement and the accompanying b |
|
| April 23, 2024 |
As filed with the Securities and Exchange Commission on April 23, 2024 As filed with the Securities and Exchange Commission on April 23, 2024 Registration No. |
|
| April 23, 2024 |
EXHIBIT 107 CALCULATION OF FILING FEE TABLES Form S-3 (Form Type) FLORA GROWTH CORP. |
|
| April 23, 2024 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of inc |
|
| April 19, 2024 |
STOCK PURCHASE AGREEMENT between TRUHC HOLDING GMBH and FLORA GROWTH CORP. dated as of April 16, 2024 TABLE OF CONTENTS ARTICLE I DEFINITIONS 6 ARTICLE II PURCHASE AND SALE 13 Section 2.01 Purchase and Sale. 13 Section 2.02 Purchase Price. 13 Section 2.03 Transactions to be Effected at the Closing. 14 Section 2.04 Closing. 15 Section 2.05 Withholding Tax. 15 ARTICLE III REPRESENTATIONS AND WARRANT |
|
| April 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 16, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of inc |
|
| April 15, 2024 |
FLGC / Flora Growth Corp. / Starke Clifford - SCHEDULE 13D - AMENDMENT 3 Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO SCHEDULE 13D Under the Securities Exchange Act of 1934 Flora Growth Corp. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 339764102 (CUSIP Number) Clifford Starke Pia Porras 75 San Francisco Panama City, Panama With a copy to: Richard Raymer Dorsey & Whitney LLP 161 Bay Street, Su |
|
| April 8, 2024 |
Underwriting Agreement, dated April 4, 2024, by and between the Company and Aegis Capital Corp. UNDERWRITING AGREEMENT April 4, 2024 Aegis Capital Corp. 1345 Avenue of the Americas, 27th Floor New York, NY 10105 Ladies and Gentlemen: FLORA GROWTH CORP., an Ontario corporation (the "Company"), agrees, subject to the terms and conditions in this agreement (this "Agreement"), to issue and sell to Aegis Capital Corp. (the "Underwriter") an aggregate of 1,700,000 of the Company's Common Shares, w |
|
| April 8, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of inco |
|
| April 5, 2024 |
Letter Agreement by and between Flora Growth Corp. and TruHC Holding GmbH, dated April 1, 2024 April 1, 2024 TRUHC HOLDING GMBH Sternstr. 97, 20357 Hamburg, Germany Attention: Mr. Hendrik Knopp Re: Acquisition of TruHC Pharma GmbH This Letter Agreement is intended to summarize the principal terms of a proposal by Flora Growth Corp. ("Flora Growth") to acquire all of the issued and outstanding shares of TruHC Pharma GmbH (the "Company"), from TruHC Holding GmbH (the "Seller") by way of a sha |
|
| April 5, 2024 |
(To Prospectus dated September 6, 2023) 1,700,000 Common Shares FLORA GROWTH CORP. Filed Pursuant to Rule 424(b)(5) Registration No. 333-274204 (To Prospectus dated September 6, 2023) 1,700,000 Common Shares FLORA GROWTH CORP. Flora Growth Corp. (the "Company" or "Flora") is offering 1,700,000 common shares, no par value, of the Company (the "common shares"), at an offering price of $1.90 per share, pursuant to this prospectus supplement and the accompanying base prospectus. Our |
|
| April 5, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 1, 2024 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of inco |
|
| April 4, 2024 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-274204 This preliminary prospectus supplement relates to an effective registration statement under the Securities Act of 1933, as amended, but the information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying base prospectus are not an offer to sell these se |
|
| March 28, 2024 |
Flora Growth Corp Incentive Compensation Recovery Policy EXHIBIT 97 FLORA GROWTH CORP. INCENTIVE COMPENSATION RECOVERY POLICY 1. Introduction. The Board of Directors of Flora Growth Corp. (the "Company") believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company's compensation philosophy. The Board has therefore adopted this p |
|
| March 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023. |
|
| March 28, 2024 |
EXHIBIT 21.1 Subsidiaries Country of Incorporation Ownership % Functional Currency Kasa Wholefoods Company LLC United States 100% United States Dollar (USD) Flora Beauty LLC United States 100% United States Dollar (USD) Vessel Brand Inc. United States 100% United States Dollar (USD) Vessel Brand Canada Inc. Canada 100% United States Dollar (USD) Just Brands LLC United States 100% United States Dol |
|
| February 14, 2024 |
SC 13G 1 annualsc13g-potxfloragrowt.htm SC 13G POTX/FLORA GROWTH CORP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION STATEMENT TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b) (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (b) Flora Growth Corp. (Name of Issuer) Common Shares (Title of Class of Securities) 339764201 ( |
|
| December 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 15, 2023 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of |
|
| December 21, 2023 |
EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT ("Agreement") is entered into this 15th day of December 2023 (the "Effective Date"), by Flora Growth Corp. |
|
| December 21, 2023 |
Consulting Agreement, dated December 15, 2023, by and between Flora Growth Corp. and Clifford Starke CONSULTING AGREEMENT This CONSULTING AGREEMENT ("Agreement") is entered into this 15th day of December 2023 (the "Effective Date"), by Flora Growth Corp. |
|
| December 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION STATEMENT TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b) (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (b) Flora Growth Corp. (Name of Issuer) Common Shares (Title of Class of Securities) 339764201 (CUSIP Number) November 30, 2023 (Date of Event Which Requires Filing o |
|
| December 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2023 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of |
|
| November 15, 2023 |
As filed with the Securities and Exchange Commission on November 15, 2023 As filed with the Securities and Exchange Commission on November 15, 2023 Registration No. |
|
| November 15, 2023 |
FLGC / Flora Growth Corp / Starke Clifford - SCHEDULE 13D A-2 Activist Investment SC 13D/A 1 sc13da.htm SCHEDULE 13D A-2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO SCHEDULE 13D Under the Securities Exchange Act of 1934 Flora Growth Corp. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 339764102 (CUSIP Number) Clifford Starke Pia Porras 75 San Francisco Panama City, Panama With a copy to: Richard Raymer |
|
| November 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2023 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of |
|
| November 15, 2023 |
EXHIBIT 107 Calculation of Filing Fee Tables FORM S-8 (Form Type) FLORA GROWTH CORP. |
|
| November 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-52776 Flora |
|
| November 3, 2023 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2023 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of i |
|
| October 25, 2023 |
October 25, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| October 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 20, 2023 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of i |
|
| October 18, 2023 |
As filed with the U.S. Securities and Exchange Commission on October 18, 2023 As filed with the U.S. Securities and Exchange Commission on October 18, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FLORA GROWTH CORP. (Exact name of Registrant as specified in its charter) Ontario, Canada 2833 Not Applicable (State or other jurisdiction of incorporation or orga |
|
| October 18, 2023 |
Exhibit 107 Calculation of Filing Fee Tables FORM S-1 (Form Type) FLORA GROWTH CORP. |
|
| October 18, 2023 |
Exhibit 21.1 List of Subsidiaries Subsidiaries Country of Incorporation Ownership % Functional Currency Cosechemos YA S.A.S. Colombia 90% Colombia Peso (COP) Hemp Textiles & Co. LLC United States 100% United States Dollar (USD) Flora Beauty LLC United States 100% United States Dollar (USD) Kasa Wholefoods Company LLC United States 100% United States Dollar (USD) Vessel Brand Inc. United States 100 |
|
| October 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 12, 2023 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of i |
|
| October 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2023 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of |
|
| September 21, 2023 |
Placement Agent Agreement, dated as of September 18, 2023, by and between the Company and A.G.P. September 18, 2023 Flora Growth Corp. 3406 SW 26th Terrace, Suite C-1 Fort Lauderdale, Florida 33312 Attention: This letter (the "Agreement") constitutes the agreement between A.G.P./Alliance Global Partners, as placement agent (the "Placement Agent"), and Flora Growth Corp., a company incorporated under the laws of the Province of Ontario (the "Company"), that the Placement Agent shall serve as t |
|
| September 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 20, 2023 (September 18, 2023) FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Province of Ontario 001-40397 Not Applicable (State or other jurisdic |
|
| September 21, 2023 |
NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. |
|
| September 21, 2023 |
Flora Growth Corp. Announces Pricing of $2.7 Million Registered Direct Offering and Concurrent Private Placement FORT LAUDERDALE, FLORIDA - September 19, 2023 - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a global consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution, announced today that it has en |
|
| September 21, 2023 |
AMENDMENT TO COMMON SHARE PURCHASE WARRANT This Amendment to Common Share Purchase Warrant (this "Amendment"), dated as of September 18, 2023, is by and between Flora Growth Corp. |
|
| September 21, 2023 |
SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this "Agreement") is dated as of September 18, 2023, between Flora Growth Corp. |
|
| September 21, 2023 |
NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. |
|
| September 20, 2023 |
FLORA GROWTH CORP. 1,369,000 Common Shares Filed Pursuant to Rule 424(b)(5) Registration No. 333-274204 Prospectus Supplement to Prospectus dated September 6, 2023 FLORA GROWTH CORP. 1,369,000 Common Shares We are offering 1,369,000 of our common shares, no par value per share (the "common shares"), directly to certain investors, referred to as "the investors." In a concurrent private placement to the same investors, we are also issuing un |
|
| September 18, 2023 |
Flora Growth Corp. to Acquire Australian Vaporizers; Expects Immediate Profit Contribution Flora Growth Corp. to Acquire Australian Vaporizers; Expects Immediate Profit Contribution FORT LAUDERDALE, FLORIDA - September 18, 2023 - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a global consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution, has entered into a definitive agreement (the "Agreem |
|
| September 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 17, 2023 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of |
|
| September 18, 2023 |
SHARE PURCHASE AGREEMENT BETWEEN LIFEIST WELLNESS INC. - and - FLORA GROWTH CORP. SEPTEMBER 17, 2023 TABLE OF CONTENTS Page ARTICLE 1 INTERPRETATION 4 1.1 Definitions 4 1.2 Certain Rules of Interpretation 11 1.3 Governing Law 12 1.4 Entire Agreement 12 1.5 Schedules and Exhibits 12 ARTICLE 2 PURCHASE AND SALE 12 2.1 Agreement of Purchase and Sale 12 2.2 Purchase Price 13 2.3 Payment of Purchase Pr |
|
| September 1, 2023 |
Flora Growth Corp. 3406 SW 26th Terrace, Suite C-1 Fort Lauderdale, Florida 33132 Flora Growth Corp. 3406 SW 26th Terrace, Suite C-1 Fort Lauderdale, Florida 33132 September 1, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Attention: Tyler Howes Re: Flora Growth Corp. - Registration Statement on Form S-3 (File No. 333-274204) Ladies and Gentlemen: In accordance with Rule 461 under the S |
|
| August 30, 2023 |
As filed with the Securities and Exchange Commission on August 30, 2023 As filed with the Securities and Exchange Commission on August 30, 2023 Registration No. |
|
| August 30, 2023 |
EXHIBIT 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Flora Growth Corp. |
|
| August 25, 2023 |
Flora Growth Corp. Unaudited Pro Forma Consolidated Statement of Loss and Comprehensive Loss (Stated in Thousands of United States Dollars) December 31, 2022 For the year ended December 31, 2022 Adjustments Flora Growth Corp. Franchise Global Health Inc. Note Acquisition of Franchise Global Health Inc. Consolidated Revenue 37,171 42,430 - 79,601 Cost of sales 22,757 39,473 2(a)(ii) (47) 62,183 Gro |
|
| August 25, 2023 |
As filed with the Securities and Exchange Commission on August 25, 2023 As filed with the Securities and Exchange Commission on August 25, 2023 Registration No. |
|
| August 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 25, 2023 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of in |
|
| August 25, 2023 |
EXHIBIT 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Flora Growth Corp. |
|
| August 10, 2023 |
AMENDMENT NO. 2 TO SHARE PURCHASE AGREEMENT This Amendment No. 2 to Share Purchase Agreement ("Amendment") is entered into and made effective as of July 13, 2023 by and between Flora Growth Corp., a Canadian corporation ("Flora") and Lisan Farma Colombia LLC, a Delaware limited liability company ("Lisan"). Flora and Lisan are collectively referred to as the "Parties" and singularly referred toas " |
|
| August 10, 2023 |
Flora Growth Corp. Reports Second Quarter 2023 Financial Results Flora Growth Corp. Reports Second Quarter 2023 Financial Results FORT LAUDERDALE, FLORIDA – August 10, 2023 – Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, reported today its financial and operating results for the three and si |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of inc |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-52776 Flora Growt |
|
| August 10, 2023 |
AMENDMENT NO. 3 TO SHARE PURCHASE AGREEMENT This Amendment No. 3 to Share Purchase Agreement ("Amendment") is entered into and made effective as of July 19, 2023 by and between Flora Growth Corp., a Canadian corporation ("Flora"), Lisan Farma Colombia LLC, a Delaware limited liability company ("Lisan") and Flora Beauty LLC, a company organized under the laws of Colorado (United States of America), |
|
| July 25, 2023 |
Flora Growth Corp. Announces Update on Sale of Colombian Assets; Expects Asset Sale to Contribute to Anticipated Annual Savings of US$6.1 million FORT LAUDERDALE, FLORIDA & TORONTO, ONTARIO - July 25, 2023 - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader serving all 50 states with 15,000+ points of distribution around the world and a pharmaceutical d |
|
| July 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 19, 2023 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) Ontario 001-40397 Not Applicable (State or other jurisdiction (Commission (IRS Employer of inco |
|
| July 11, 2023 |
EXHIBIT 10.1 SHARE PURCHASE AGREEMENT BY AND AMONG Flora Growth Corp. (referred to as the “Seller”) AND Lisan Farma Colombia LLC. (referred to as the “Purchaser”) Dated July 5, 2023 SHARE PURCHASE AGREEMENT This Share Purchase Agreement (hereinafter, the “Agreement”) is entered into on July 5th, 2023 by and between: (1) Flora Growth Corp., a company organized under the laws of the Republic of Cana |
|
| July 11, 2023 |
EXHIBIT 10.2 AMENDMENT NO. 1 TO SHARE PURCHASE AGREEMENT This Amendment No. 1 to Share Purchase Agreement (“Amendment”) is entered into and made effective as of July 7, 2023 by and between Flora Growth Corp., a Canadian corporation (“Flora”) and Lisan Farma Colombia LLC, a Delaware limited liability company (“Lisan”). Flora and Lisan are collectively referred to as the “Parties” and singularly ref |
|
| July 11, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 5, 2023 Flora Growth Corp. (Exact Name of Registrant as Specified in Its Charter) Province of Ontario 001-40397 Not Applicable (State or other jurisdiction of incorporation) (Com |
|
| June 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2023 Flora Growth Corp. (Exact Name of Registrant as Specified in Its Charter) Province of Ontario 001-40397 Not Applicable (State or other jurisdiction of incorporation) (Co |
|
| June 27, 2023 |
EXHIBIT 99.1 Flora Growth Corp. appoints Clifford Starke as Chief Executive Officer and Dany Vaiman as Chief Financial Officer; Regains compliance with NASDAQ minimum bid requirement FORT LAUDERDALE, FLORIDA – June 27, 2023 – Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a consumer-packaged goods leader serving all 50 states with 15,000+ points of distribution around the world and |
|
| June 27, 2023 |
EXHIBIT 10.3 SEPARATION AGREEMENT AND GENERAL RELEASE Ther Separation Agreement and General Release (“Agreement”) is made effective as defined below in Subsection 16(E) (“Agreement Effective Date”), by and between Jessie Casner (hereinafter referred to as “Casner”), Flora Growth Management Corp. (“Flora Management”) and Flora Growth Corp. (“Flora Growth” and together with Flora Management, hereina |
|
| June 27, 2023 |
EXHIBIT 10.2 SEPARATION AGREEMENT AND GENERAL RELEASE This Separation Agreement and General Release (“Agreement”) is made effective as defined below in Subsection 16(E) (“Agreement Effective Date”), by and between Elshad Garayev (hereinafter referred to as “Garayev”), Flora Growth Management Corp. (“Flora Management”) and Flora Growth Corp. (“Flora Growth” and together with Flora Management, herei |
|
| June 27, 2023 |
EXHIBIT 10.4 SEPARATION AGREEMENT AND GENERAL RELEASE This Separation Agreement and General Release (“Agreement”) is made effective as defined below in Subsection 16(E) (“Agreement Effective Date”), by and between Jason Warnock (hereinafter referred to as “Warnock”), Flora Growth Management Corp. (“Flora Management”) and Flora Growth Corp. (“Flora Growth” and together with Flora Management, herein |
|
| June 27, 2023 |
EXHIBIT 10.1 SEPARATION AGREEMENT AND GENERAL RELEASE This Separation Agreement and General Release (“Agreement”) is made effective as defined below in Subsection 16(E) (“Agreement Effective Date”), by and between Hussein Rakine (hereinafter referred to as “Rakine”), Flora Growth Management Corp. (“Flora Management”) and Flora Growth Corp. (“Flora Growth” and together with Flora Management, herein |
|
| June 7, 2023 |
Articles of Amendment of Flora Growth Corp. effective June 9, 2023 EXHIBIT 3.1 |
|
| June 7, 2023 |
Flora Growth Corp. to Effect Reverse Stock Split EXHIBIT 99.1 Flora Growth Corp. to Effect Reverse Stock Split FORT LAUDERDALE, FLORIDA & TORONTO, June 7, 2023 - Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a global cultivator, manufacturer, and distributor of cannabis products and brands, announces that it will effect a reverse stock split, which shall become effective on June 9, 2023 at a ratio of 1-for-20 (the “Reverse Stock |
|
| June 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2023 Flora Growth Corp. (Exact Name of Registrant as Specified in Its Charter) Province of Ontario 001-40397 Not Applicable (State or other jurisdiction of incorporation) (Com |
|
| June 6, 2023 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2023 Flora Growth Corp. (Exact Name of Registrant as Specified in its Charter) Province of Ontario 001-40397 Not Applicable (State or Other Jurisdiction of Incorporation) (Com |
|
| May 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| May 18, 2023 |
EXHIBIT 10.1 AMENDMENT NO. 1 TO SEPARATION AGREEMENT AND GENERAL RELEASE This Amendment No. 1 to Separation Agreement and General Release (“Amendment”) is entered into and made effective as of May 14, 2023 by and between Luis Merchan (hereinafter referred to as “Merchan”), Flora Growth Management Corp. (“Flora Management”) and Flora Growth Corp. (“Flora Growth” and together with Flora Management, |
|
| May 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2023 Flora Growth Corp. (Exact Name of Registrant as Specified in Its Charter) Province of Ontario 001-40397 Not Applicable (State or other jurisdiction of incorporation) (Com |
|
| May 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022. |
|
| May 15, 2023 |
Flora Growth Reports First Quarter 2023 Financial Results EXHIBIT 99.1 Flora Growth Reports First Quarter 2023 Financial Results · Flora generated $20.1 million in revenue in Q1 2023, a 307% increase year-over-year. · Gross profit for Q1 2023 increased 105% year-over-year, to $5.5 million. · Posted a net loss of $3.9 million for Q1 2023 (decreased from Q1 2022). New leadership plans to further reduce expenses and focus on organic revenue growth. FORT LAU |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-52776 Flora Grow |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2023 Flora Growth Corp. (Exact Name of Registrant as Specified in Its Charter) Province of Ontario 001-40397 Not Applicable (State or other jurisdiction of incorporation) (Com |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| May 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A (Amendment No. |
|
| April 21, 2023 |
EX-99.1 2 e618528ex99-1.htm JOINT FILING AGREEMENT, DATED APRIL 21, 2023 Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the common shares, no par valu |
|
| April 21, 2023 |
FLGC / Flora Growth Corp / Starke Clifford - AMENDMENT NO. 1 TO THE SCHEDULE 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. |
|
| April 21, 2023 |
FLGC / Flora Growth Corp / Starke Clifford - SUPPORT AND VOTING AGREEMENT Activist Investment begin 644 e618528994.pdf M)5!$1BTQ+C4-)7!E+T-A=&%L;V7!E+T=R;W5P+U,O5')A;G-P87)E;F-Y M+T-3+T1E=FEC95)'0CX^+U1A8G,O4R]3=')U8W1087)E;G1S(# ^/@T*96YD M;V)J"C0@,"!O8FH*/#PO1FEL=&5R+T9L871E1&5C;V1E+TQE;F=T:" T,#0Y M/CYS=')E86T-"GB<=>S*U M-9D'69+M[#JBH\O,9+]^ 31)228AV12D5#FV)5('C48#!V@T?7(ZG7^Y'@SG MP8\GIS.YX/A[7@4'9R6=S?G+Y7Y\\G%P\V4RF'\I)B<7BZLYOO1V/!B- MI\^?!R]>G@7?CHB*,9N=)!'#CX/\UU,!T?'WZMV!R?/3B\OC |
|
| April 18, 2023 |
EXHIBIT 10.2 EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is made as of April 16, 2023 (the “Agreement Date”), with an effective date of April 16, 2023 (the “Effective Date”), by Flora Growth Management Corp., a Florida corporation with a principal business address located at 3406 SE 26th Terrace, Fort Lauderdale, FL 33312 (“Flora Management”), and Hussein Rakin |
|
| April 18, 2023 |
EXHIBIT 10.1 SEPARATION AGREEMENT AND GENERAL RELEASE This Separation Agreement and General Release (“Agreement”) is made effective as defined below in Subsection 16(E) (“Agreement Effective Date”), by and between Luis Merchan (hereinafter referred to as “Merchan”), Flora Growth Management Corp. (“Flora Management”) and Flora Growth Corp. (“Flora Growth” and together with Flora Management, hereina |
|
| April 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 12, 2023 Flora Growth Corp. (Exact Name of Registrant as Specified in Its Charter) Province of Ontario 001-40397 Not Applicable (State or other jurisdiction of incorporation) (C |
|
| April 18, 2023 |
EXHIBIT 99.1 Flora Growth Corp. Announces the Appointment of Hussein Rakine as CEO and Member of the Board of Directors FORT LAUDERDALE, FLORIDA– April 18, 2023 – Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”) a leading cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its board of directors (the “Board”) accepted the resignation of |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2023 Flora Growth Corp. (Exact Name of Registrant as Specified in Its Charter) Province of Ontario 001-40397 Not Applicable (State or other jurisdiction of incorporation) (C |
|
| March 31, 2023 |
Flora Growth Reports 2022 Year-End Financial Results: $37.2M in Revenue, 314% Growth Year-Over-Year EX-99.1 2 floraex991.htm PRESS RELEASE EXHIBIT 99.1 Flora Growth Reports 2022 Year-End Financial Results: $37.2M in Revenue, 314% Growth Year-Over-Year · Flora generated $37.2 million in revenue in FY2022, a 314% increase YoY · Record Q4 2022 revenue increased to $11.5 million, a 7% sequential increase from Q3 2022 · Gross profit for FY2022 increased by 494%, from $2.4 million to $14.4 million YoY |
|
| March 31, 2023 |
EXHIBIT 10.10 EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is entered into this 23rd day of December 2022 (the “Effective Date”), by Flora Growth Corp., a Toronto, Ontario corporation with a principal business address located at365 Bay Street, Suite 800, Toronto, ON M5H 2V1 (“Flora Growth”), and Dany Vaiman (“Executive”). Executive and Flora Growth are referred |
|
| March 31, 2023 |
EXHIBIT 21.1 Subsidiaries Country of Incorporation Ownership % Functional Currency Cosechemos YA S.A.S. Colombia 90% Colombia Peso (COP) Flora Growth Corp. Sucursal Colombia Colombia 100% Colombia Peso (COP) Hemp Textiles & Co. LLC United States 100% United States Dollar (USD) Hemp Textiles & Co. S.A.S. Colombia 100% Colombia Peso (COP) Flora Beauty LLC United States 100% United States Dollar (USD |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022. |
|
| March 31, 2023 |
EXHIBIT 10.8 CONSULTING AGREEMENT This CONSULTANTING AGREEMENT (“Agreement”) is entered into this 23rd day of December 2022 (the “Effective Date”), by Flora Growth Corp., an Ontario corporation with a principal business address located at 365 Bay Street, Suite, 800, Toronto, ON M5H 2V1 (“Flora Growth”), and Clifford Starke (“Consultant”). Consultant and Flora Growth are referred to as “Parties” or |
|
| January 30, 2023 |
EXHIBIT 99.1 Flora Growth Issues 2023 Revenue Guidance of $90 Million to $105 Million Reflecting Anticipated Year Over Year Growth Exceeding 100% - Flora will host a webcast discussing 2023 guidance and recapping 2022 milestones at 4:30 pm ET on January 30, 2023. Register and join here. FORT LAUDERDALE, FLORIDA, – January 30, 2023 - Flora Growth Corp. (NASDAQ: FLGC) (“Flora’’ or the “Company”), a |
|
| January 30, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2023 Flora Growth Corp. (Exact Name of Registrant as Specified in Its Charter) Province of Ontario 001-40397 Not Applicable (State or other jurisdiction of incorporation) |
|
| January 6, 2023 |
EXHIBIT 99.1 Flora Growth Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule FORT LAUDERDALE, FLORIDA, TORONTO, ONTARIO ? January 6, 2023 - Flora Growth Corp. (NASDAQ: FLGC) (?Flora'' or the ?Company?), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today it received an extension of 180 |
|
| January 6, 2023 |
FLGC / Flora Growth Corp. / Starke Clifford - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Flora Growth Corp. (Name of Issuer) Common Shares, no par value per share (Title of Class of Securities) 339764102 (CUSIP Number) Clifford Starke PH Park Loft #2006, Via Porras 75, San Francisco, Panama City, Panama (Name, Address and Telephone Number of |
|
| January 6, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2023 Flora Growth Corp. (Exact Name of Registrant as Specified in Its Charter) Ontario, Canada 001-40397 Not Applicable (State or other jurisdiction of incorporation) (Comm |
|
| December 27, 2022 |
EX-99.2 3 floraex992.htm CONSULTING AGREEMENT EXHIBIT 99.2 CONSULTING AGREEMENT This CONSULTANTING AGREEMENT (“Agreement”) is entered into this day of December 2022 (the “Effective Date”), by Flora Growth Corp., an Ontario corporation with a principal business address located at 365 Bay Street, Suite, 800, Toronto, ON M5H 2V1 (“Flora Growth”), and Clifford Starke (“Consultant”). Consultant and Flo |
|
| December 27, 2022 |
EXHIBIT 99.1 Flora Growth Closes Acquisition of Franchise Global Health, Cementing Foothold in Germany and the European Union ? The transformative acquisition is expected to connect Flora Growth?s Colombian-grown cannabis directly with German-based pharmaceutical and medical cannabis distribution. ? The deal establishes a foothold in Germany allowing for medical cannabis sales across 1,200+ pharma |
|
| December 27, 2022 |
6-K 1 flora6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2022 Commission File Number 001-40397 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) 3406 SW 26th Terrace, Suite C-1 Fort Lauderda |
|
| December 13, 2022 |
EXHIBIT 99.1 Flora Growth Corp. Announces Pricing of $5.0 Million Registered Direct Offering FORT LAUDERDALE, FLORIDA & TORONTO, December 9, 2022-(BUSINESS WIRE)-Flora Growth Corp. (NASDAQ: FLGC) ("Flora'' or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today that it has entered into securities purchase agreements |
|
| December 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2022 Commission File Number 001-40397 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) 365 Bay Street, Suite 800 Toronto, Ontario M5H 2V1 (Address of Principal |
|
| December 13, 2022 |
EXHIBIT 4.2 COMMON SHARE PURCHASE WARRANT FLORA GROWTH CORP. Warrant Shares: Issue Date: December 13, 2022. THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the 181st day immediately following th |
|
| December 13, 2022 |
EXHIBIT 1.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December 8, 2022, between Flora Growth Corp., a corporation organized under the laws of the Province of Ontario (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). WHERE |
|
| December 13, 2022 |
EXHIBIT 4.1 COMMON SHARE PURCHASE WARRANT FLORA GROWTH CORP. Warrant Shares: Issue Date: December 13, 2022. THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exerc |
|
| December 9, 2022 |
424B5 1 flora424b5.htm 424B5 Filed Pursuant to Rule 424(b)(5) Registration No. 333-267585 Prospectus Supplement to Prospectus dated October 5, 2022 FLORA GROWTH CORP. 12,500,000 Common Shares Investor Warrants to Purchase Up to 12,500,000 Common Shares Placement Agent Warrants to Purchase Up to 500,000 Common Shares We are offering 12,500,000 of our common shares, no par value per share (the “comm |
|
| November 28, 2022 |
EXHIBIT 99.2 Flora Growth Corp. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the three and nine months ended September 30, 2022 and 2021 (Unaudited) (Expressed in United States Dollars) Flora Growth Corp. Interim Condensed Consolidated Statements of Financial Position (Unaudited - Prepared by Management) (in thousands of United States dollars) As at: September 30, 2022 December 31, 2021 |
|
| November 28, 2022 |
Flora Growth Reports Third Quarter 2022 Financial Results EXHIBIT 99.1 Flora Growth Reports Third Quarter 2022 Financial Results ● Revenue for the three-month period ended September 30, 2022 was $10.8 million, an increase of 414% year over year ● Revenue for the nine-month period ended September 30, 2022 was $25.7 million, an increase of 510% year over year ● Gross profit for the three-month period ended September 30, 2022 was $5.0 million, an increase o |
|
| November 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number 001-40397 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) 365 Bay Street, Suite 800 Toronto, Ontario M5H 2V1 (Address of Principal |
|
| October 24, 2022 |
EX-99.3 4 floraex993.htm AUDITED CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 99.3 Franchise Cannabis Corp. Consolidated Financial Statements For the years ended December 31, 2020 and 2019 Expressed in Canadian Dollars Contents Independent Auditor’s Report 2 Consolidated Financial Statements Consolidated Statements of Financial Position 4 Consolidated Statements of Comprehensive Loss 5 Consolidated S |
|
| October 24, 2022 |
EXHIBIT 99.6 Flora Growth Corp. Unaudited Pro Forma Consolidated Financial Statements (United States Dollars, unless otherwise noted) June 30, 2022 Flora Growth Corp. Unaudited Pro Forma Consolidated Statement of Financial Position (Stated in Thousands of United States Dollars) Adjustments As at June 30, 2022 Assets Flora Growth Corp. Franchise Global Health Inc. Note Acquisition of Franchise Glob |
|
| October 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2022 Commission File Number 001-40397 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) 365 Bay Street, Suite 800 Toronto, Ontario M5H 2V1 (Address of Principal |
|
| October 24, 2022 |
EX-99.5 6 floraex995.htm UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 99.5 Franchise Global Health Inc. Unaudited Condensed Consolidated Interim Financial Statements June 30, 2022 and 2021 Expressed in Canadian Dollars Contents Condensed Consolidated Interim Financial Statements Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Co |
|
| October 24, 2022 |
Consent of Independent Registered Public Accounting Firm EXHIBIT 99.7 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement on Form F-3 (File No. 333-267585) and the Registration Statements on Form S-8 (File Nos. 333-259198, 333-262660 and 333-266400) of Flora Growth Corp. of our audit report dated March 9, 2022 for the year ended December 31, 2020, with respect to the consoli |
|
| October 24, 2022 |
EXHIBIT 99.4 Franchise Cannabis Corp. Consolidated Financial Statements For the years ended December 31, 2021 and 2020 Expressed in Canadian Dollars Contents Consolidated Financial Statements Independent Auditors? Report 2 Consolidated Statements of Financial Position 4 Consolidated Statements of Loss and Comprehensive Loss 5 Consolidated Statements of Changes in Shareholders? Equity 6 Consolidate |
|
| October 24, 2022 |
EXECUTIVE EMPLOYMENT AGREEMENT EX-99.10 11 floraex9910.htm FORM OF EMPLOYMENT AGREEMENT FOR DANY VAIMAN EXHIBIT 99.10 EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is entered into this day of December 2022 (the “Effective Date”), by Flora Growth Management Corp., a Florida corporation with a principal business address located at3406 SW 26th Terrace, Suite C-1, Fort Lauderdale, FL 33312 (“Flora |
|
| October 24, 2022 |
EXECUTIVE EMPLOYMENT AGREEMENT EX-99.9 10 floraex999.htm FORM OF EMPLOYMENT AGREEMENT FOR CLIFFORD STARKE EXHIBIT 99.9 EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is entered into this day of December 2022 (the “Effective Date”), by Flora Growth Management Corp., a Florida corporation with a principal business address located at3406 SW 26th Terrace, Suite C-1, Fort Lauderdale, FL 33312 (“Flor |
|
| October 24, 2022 |
EX-99.1 2 floraex991.htm ARRANGEMENT AGREEMENT, DATED OCTOBER 21, 2022 EXHIBIT 99.1 ARRANGEMENT AGREEMENT FLORA GROWTH CORP. - and - FRANCHISE GLOBAL HEALTH INC. October 21, 2022 TABLE OF CONTENTS ARTICLE 1 INTERPRETATION 2 1.1. Defined Terms 2 1.2. Certain Rules of Interpretation 15 1.3. Schedules 16 ARTICLE 2 THE ARRANGEMENT 16 2.1. The Arrangement 16 2.2. Interim Order 17 2.3. The Company Meeti |
|
| October 24, 2022 |
Consent of Independent Registered Public Accounting Firm EXHIBIT 99.8 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement on Form F-3 (File No. 333-267585) and the Registration Statements on Form S-8 (File Nos. 333-259198, 333-262660 and 333-266400) of Flora Growth Corp. of our audit report dated April 27, 2022 for the year ended December 31, 2021, with respect to the consol |
|
| October 24, 2022 |
EX-99.2 3 floraex992.htm PRESS RELEASE EXHIBIT 99.2 Flora Growth Signs Definitive Agreement to Acquire Franchise Global Health, a Prominent Pharmaceutical and Medical Cannabis Distributor with Principal Operations in Germany · The transformative deal is expected to connect Flora Growth’s Colombian-grown cannabis directly with German-based pharmaceutical and medical cannabis distribution. · The dea |
|
| October 3, 2022 |
Flora Growth Corp. 365 Bay Street, Suite 800 Toronto, Ontario, M5H 2V1 CORRESP 1 filename1.htm Flora Growth Corp. 365 Bay Street, Suite 800 Toronto, Ontario, M5H 2V1 October 3, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attention: Margaret Schwartz RE: Flora Growth Corp. (the “Company”) Registration Statement on Form F-3 (the “Registration Statement”) Filed September 23, 2022 |
|
| September 23, 2022 |
As filed with the Securities and Exchange Commission on September 23, 2022 As filed with the Securities and Exchange Commission on September 23, 2022 Registration No. |
|
| September 23, 2022 |
EX-FILING FEES 5 floraex107.htm FILING FEE TABLE EXHIBIT 107 CALCULATION OF FILING FEE TABLES Form F-3 (Form Type) Flora Growth Corp. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggre |
|
| September 19, 2022 |
EXHIBIT 99.1 Flora Growth Corp. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the six months ended June 30, 2022 and 2021 (Unaudited) (Expressed in United States Dollars) Flora Growth Corp. Interim Condensed Consolidated Statements of Financial Position (Unaudited - Prepared by Management) (in thousands of United States dollars) As at: June 30, 2022 December 31, 2021 ASSETS Current Cash |
|
| September 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K/A Amendment No. 1 REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number 001-40397 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) 365 Bay Street, Suite 800 Toronto, ONtario M5H 2V1 (A |
|
| September 16, 2022 |
EXHIBIT 4.8 INDEPENDENT CONTRACTOR AGREEMENT THIS AGREEMENT is made as of the 1st day of December 2021 BETWEEN: FLORA GROWTH CORP., a body corporate duly incorporated under the laws of the Province of Ontario, with an address of 198 Davenport Road, Toronto, Ontario M5R 1J2 (hereinafter called the ?Company?) AND: OF THE FIRST PART DR. ANNABELLE MANALO-MORGAN, an individual with an address of 2020 F |
|
| September 16, 2022 |
EXHIBIT 2.1 The rights of shareholders of Flora Growth Corp. (?Flora,? ?we,? ?our,? ?us,? or the ?Company?) are governed by the Business Corporations Act (Ontario) (the ?OBCA?), Flora's Articles of Incorporation (as amended) (?Articles?), and Flora's by-laws (?By-laws?). Our authorized share capital consists of an unlimited number of common shares (?Common Shares?), without nominal or par value. I |
|
| September 16, 2022 |
EXHIBIT 4.1 EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (?Agreement?) is made as of February 28, 2022 (the ?Agreement Date?), with an effective date of March 1, 2022 (the ?Effective Date?), by Flora Growth Management Corp., a Florida corporation with a principal business address located at 198 Davenport Road, Toronto, Ontario, M5R 1J2, Canada (?Flora Management?), and Luis M |
|
| September 16, 2022 |
EXHIBIT 12.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES OXLEY ACT OF 2002 I, Luis Merchan, certify that: 1. I have reviewed this Annual Report on Form 20-F/A of Flora Growth Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which |
|
| September 16, 2022 |
Certification of the Chief Financial Officer pursuant to 18 U.S.C. 1350, furnished herewith. EXHIBIT 13.2 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES OXLEY ACT OF 2002 I, Elshad Garayev, Chief Financial Officer of Flora Growth Corp. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350 that, to the best of my knowledge: 1. the Annual Report on Form 20-F/A of the Company for the year ended December 31, 2021 (the “Report”) full |
|
| September 16, 2022 |
Consent of Davidson & Company LLP, independent registered public accounting firm. EXHIBIT 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in each of the Flora Growth Corp.?s Registration Statements on Form S-8 (No. 333-25918, No . 333-262660 and No. 333-259198) of our report dated May 9, 2022, relating to the consolidated financial statements of Flora Growth Corp., which appears in this Form 20-F /A . /s/ DAVIDSO |
|
| September 16, 2022 |
EXHIBIT 4.3 EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (?Agreement?) is made as of February 28, 2022 (the ?Agreement Date?), with an effective date of March 1, 2022 (the ?Effective Date?), by Flora Growth Management Corp., a Florida corporation with a principal business address located at 198 Davenport Road, Toronto, Ontario, M5R 1J2, Canada (?Flora Management?), and Matthe |
|
| September 16, 2022 |
EXHIBIT 4.7 INDEPENDENT CONTRACTOR AGREEMENT THIS AGREEMENT is made as of the 15th day of March 2022 BETWEEN: FLORA GROWTH CORP., a body corporate duly incorporated under the laws of the Province of Ontario (hereinafter called the ?Company?) AND: OF THE FIRST PART Dr. Bernard Wilson, an individual residing in Canada (hereinafter called the ?Consultant?) OF THE SECOND PART FOR VALUABLE CONSIDERATIO |
|
| September 16, 2022 |
EXHIBIT 4.5 EXECUTIVE EMPLOYMENT AGREEMENT The EXECUTIVE EMPLOYMENT AGREEMENT (?Agreement?) is made as of February 28, 2022 (the ?Agreement Date?), with an effective date of March 1, 2022 (the ?Effective Date?), by Flora Growth Management Corp., a Florida corporation with a principal business address located at 198 Davenport Road, Toronto, Ontario, M5R 1J2, Canada (?Flora Management?), and Jessie |
|
| September 16, 2022 |
EXHIBIT 4.4 CONSULTING AGREEMENT This CONSULTING AGREEMENT (?Agreement?) is made as of February 28, 2022 (the ?Agreement Date?), with an effective date of March 1, 2022 (the ?Effective Date?), by Flora Growth Management Corp., a Florida corporation with a principal business address located at 3406 SW 26th Terrace, Fort Lauderdale, FL 33312 (?Flora Management?), and Jason Warnock (?Consultant?). Co |
|
| September 16, 2022 |
EXHIBIT 12.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES OXLEY ACT OF 2002 I, Elshad Garayev, certify that: 1. I have reviewed this Annual Report on Form 20-F/A of Flora Growth Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under whi |
|
| September 16, 2022 |
EXHIBIT 4.2 EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (?Agreement?) is made as of February 28, 2022 (the ?Agreement Date?), with an effective date of March 1, 2022 (the ?Effective Date?), by Flora Growth Management Corp., a Florida corporation with a principal business address located at 198 Davenport Road, Toronto, Ontario M5R 1J2, Canada (?Flora Management?), and James C |
|
| September 16, 2022 |
Certification of the Chief Executive Officer pursuant to 18 U.S.C. 1350, furnished herewith. EXHIBIT 13.1 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES OXLEY ACT OF 2002 I, Luis Merchan, Chief Executive Officer of Flora Growth Corp. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350 that, to the best of my knowledge: 1. the Annual Report on Form 20-F/A of the Company for the year ended December 31, 2021 (the “Report”) fully |
|
| September 16, 2022 |
United States Securities and Exchange Commission Washington, D.C. 20549 FORM 20-F/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Commission file number 001-40397 Flora Growth Corp. (Exact name of Registrant as specified in its charter) Province of Ontario (Jurisdiction of incorporation or organiza |
|
| August 15, 2022 |
Flora Growth Reports H1 2022 Financial Results EXHIBIT 99.1 Flora Growth Reports H1 2022 Financial Results ? H1 2022 revenue increased to ~$15.0 million, up 604% from H1 2021 and 117% from H2 2021, driven by House of Brands ? Gross Profit increased to ~$7.0 million, up 547% compared to H1 2021 and 363% compared to H2 2021 ? Company reaffirms its 2022 revenue guidance to range between $35.0 million - $45.0 million, indicating approximately 300% |
|
| August 15, 2022 |
EXHIBIT 99.2 Flora Growth Corp. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the six months ended June 30, 2022 and 2021 (Unaudited) (Expressed in United States Dollars) Flora Growth Corp. Interim Condensed Consolidated Statements of Financial Position (Unaudited - Prepared by Management) (in thousands of United States dollars) As at: June 30, 2022 December 31, 2021 ASSETS Current Cash |
|
| August 15, 2022 |
For the six months ended June 30, 2022 EXHIBIT 99.3 Operating and Financial Review and Prospects For the six months ended June 30, 2022 and 2021 Management?s Discussion and Analysis of Financial Condition and Results of Operations The following Management?s Discussion and Analysis of Financial Condition and Results of Operations (?MD&A?) of Flora Growth Corp. (the ?Company? or ?Flora?) should be read in conjunction with the Company?s a |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number 001-40397 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) 365 Bay Street, Suite 800 Toronto, Ontario M5H 2V1 (Address of Principal E |
|
| July 29, 2022 |
EXHIBIT 107 CALCULATION OF FILING FEE TABLE FORM S-8 (Form Type) Flora Growth Corp. |
|
| July 29, 2022 |
As filed with the Securities and Exchange Commission on July 29, 2022 As filed with the Securities and Exchange Commission on July 29, 2022 Registration No. |
|
| July 14, 2022 |
6-K 1 flora6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number 001-40397 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) 365 Bay Street, Suite 800 Toronto, Ontario M5H 2V |
|
| July 11, 2022 |
6-K 1 flora6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number 001-40397 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) 365 Bay Street, Suite 800 Toronto, Ontario M5H 2V |
|
| July 11, 2022 |
Flora Growth Taps Amazon Executive Elshad Garayev As Chief Financial Officer EX-99.2 3 floraex992.htm PRESS RELEASE EXHIBIT 99.2 Flora Growth Taps Amazon Executive Elshad Garayev As Chief Financial Officer · Former Amazon financial operations excellence leader and leading e-commerce platform strategist to assist Flora with financial discipline and reporting · Garayev brings 25 years of financial leadership experience at Amazon, Boeing, BP and RPK Capital, and will focus on |
|
| July 11, 2022 |
EXECUTIVE EMPLOYMENT AGREEMENT EX-99.1 2 floraex991.htm EXECUTIVE EMPLOYMENT AGREEMENT EXHIBIT 99.1 EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is made as of July 7, 2022 (the “Agreement Date”), with an effective date of July 21, 2022 (the “Effective Date”), by Flora Growth Management Corp., a Florida corporation with a principal business address located at 3406 SW 26th Terrace, Suite C-1, F |
|
| July 6, 2022 |
EX-99.1 2 floraex991.htm PRESS RELEASE EXHIBIT 99.1 Flora Growth Announces Results of Annual Meeting of Shareholders; Appointment of Brandon Konigsberg to Board of Directors FORT LAUDERDALE, FLORIDA, TORONTO, ONTARIO – July 06, 2022 - Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, |
|
| July 6, 2022 |
FLORA GROWTH CORP. (the “Corporation”) BY-LAW NO. 1-A EXHIBIT 99.3 FLORA GROWTH CORP. (the “Corporation”) BY-LAW NO. 1-A A by-law relating generally to the transaction of the business and affairs of the Corporation. CONTENTS Article 1 - Interpretation Article 2 - Business of the Corporation Article 3 - Borrowing and Debt Obligations Article 4 - Directors Article 5 - Committees Article 6 - Officers Article 7 - Protection of Directors, Officers and Oth |
|
| July 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number 001-40397 FLORA GROWTH CORP. (Exact name of registrant as specified in its charter) 365 Bay Street, Suite 800 Toronto, Ontario M5H 2V1 (Address of Principal Exe |
|
| July 6, 2022 |
EXHIBIT 99.2 FLORA GROWTH CORP. 2022 INCENTIVE COMPENSATION PLAN FLORA GROWTH CORP. 2022 INCENTIVE COMPENSATION PLAN 1. Purpose 1 2. Definitions 1 3. Administration. 7 4. Shares Subject to Plan. 7 5. Eligibility 8 6. Specific Terms of Awards. 8 7. Certain Provisions Applicable to Awards. 13 8. Change in Control. 15 9. General Provisions. 16 2 FLORA GROWTH CORP. 2022 INCENTIVE COMPENSATION PLAN 1. |
